ADVENTRX Pharmaceuticals, Inc. Amended and Restated 2008 Omnibus Incentive Plan Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • November 5th, 2012 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 5th, 2012 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of [ ] (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Santosh Vetticaden (the “Grantee”).
ADVENTRX Pharmaceuticals, Inc. Amended and Restated 2008 Omnibus Incentive Plan Senior Executive Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • March 8th, 2012 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 8th, 2012 Company Industry JurisdictionTHIS SENIOR EXECUTIVE INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Grantee”).
ADVENTRX Pharmaceuticals, Inc. 2008 Omnibus Incentive Plan Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • May 9th, 2011 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMay 9th, 2011 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of February 1, 2011 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Patrick L. Keran (the “Grantee”).
ADVENTRX Pharmaceuticals, Inc. 2008 Omnibus Incentive Plan Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • May 9th, 2011 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMay 9th, 2011 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of February 1, 2011 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Brian M. Culley (the “Grantee”).
Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • January 26th, 2010 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJanuary 26th, 2010 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of , 2010 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Patrick L. Keran (the “Grantee”).
Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • January 26th, 2010 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJanuary 26th, 2010 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of , 2010 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Brian M. Culley (the “Grantee”).
Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • July 22nd, 2009 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 22nd, 2009 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of July 21, 2009 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Brian M. Culley (the “Grantee”).
Incentive Stock Option Grant AgreementIncentive Stock Option Grant Agreement • July 22nd, 2009 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 22nd, 2009 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION GRANT AGREEMENT (this “Agreement”), effective as of July 21, 2009 (the “Grant Date”), is entered into by and between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Patrick L. Keran (the “Grantee”).